WILMINGTON – Incyte Corp. reported a “disappointing” conclusion Monday to its study of its blockbuster drug Jakafi to fight the effects of COVID-19 in hospitalized patients. The pharmaceutical company headquartered […]
© 2024 Delaware Business Times